MedTrace Logo

Vitamin D Levels and Survival in Cancer Patients

NCT03266887 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5764

Last updated 2017-08-30

No results posted yet for this study

Summary

Using the population-based data sources in Iceland and the well-characterized AGES-Reykjavik cohort, our overarching aims are on exploring whether pre-diagnostic serum levels of 25-hydroxyvitamin D (25(OH)D) among older individuals living in Iceland were associated with survival after cancer diagnosis. We also wanted to assess the risk of being diagnosed with cancer in association with 25(OH)D levels. In this population living just south of the arctic circle, vitamin D levels largely depend on dietary- and supplemental sources.

Conditions

  • Neoplasms

Sponsors & Collaborators

  • University of Iceland

    collaborator OTHER

  • Icelandic Heart Association

    lead OTHER

Eligibility

Min Age
66 Years
Max Age
98 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-01
Primary Completion
2006-12-30
Completion
2006-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03266887 on ClinicalTrials.gov